Clinical Trial Update: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating Ambisome alone and in combination with Miltefosine for treatment of visceral leishmaniasis in HIV-positive Ethiopian pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• Miltefosine (miltefosine)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Visceral Leishmaniasis | Phase 3 | Status: COMPLETED